Publications by authors named "Pierre Triozzi"

Claim this Profile
R
Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance status.
Safoa Addo, Thomas Lycan, David R Soto-Pantoja, Yu-Ting Tsai, Ericson Stoen, Pierre Triozzi

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Options for Brain Metastases.
Ariel Choi, John Hunting, Claire Lanier, Emily Douglas, Pierre Triozzi

Curr Treat Options Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.
Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Pierre L Triozzi

Cancer Res Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Pierre Triozzi

Ther Adv Med Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
Ryan T Hughes, Rediet R Gebeyehu, John Mason Kalada, Thomas W Lycan, Bart A Frizzell, Pierre Triozzi

Future Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain Metastases.
Mohammed Abdulhaleem, Hannah Johnston, Ralph D'Agostino, Claire Lanier, Christina K Cramer, Pierre Triozzi

Neurosurg Pract· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.
Aung Naing, Alain P Algazi, Gerald S Falchook, Benjamin C Creelan, John Powderly, Pierre L Triozzi

Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.
Elizabeth R Stirling, Masaki Terabe, Adam S Wilson, Mitra Kooshki, Liliya M Yamaleyeva, Pierre L Triozzi

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A First Suspected Case of Fibrosing Mediastinitis After Anti-PD-1 Therapy.
Carolyn J Park, Sujethra Vasu, Jean L Urbain, Pierre L Triozzi, Yashashwi Pokharel

JACC Case Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden.
Shailaja K S Raj, Eric D Routh, Jeff W Chou, Konstantinos I Votanopoulos, Pierre L Triozzi

Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy.
Yong Lu, Gang Xue, Ningbo Zheng, Kun Han, Wenzhong Yang, Pierre L Triozzi

Brief Bioinform· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade.
Pierre L Triozzi, Elizabeth R Stirling, Qianqian Song, Brian Westwood, Mitra Kooshki

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Implications of Immune Checkpoint Proteins in Cancer.
Elizabeth R Stirling, Steven M Bronson, Jessica D Mackert, Katherine L Cook, Pierre L Triozzi

Cells· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy.
Corbin A Helis, Ryan T Hughes, Chase W Glenn, Claire M Lanier, Adrianna H Masters, Pierre Triozzi

Int J Radiat Oncol Biol Phys· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study.
Konstantinos I Votanopoulos, Steven Forsythe, Hemamylammal Sivakumar, Andrea Mazzocchi, Julio Aleman, Pierre Triozzi

Ann Surg Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.
Elaine Binkley, Pierre L Triozzi, Lisa Rybicki, Susan Achberger, Wayne Aldrich

Br J Ophthalmol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery.
Michael H Soike, Jennifer Logue, Shadi Qasem, Ryan T Hughes, Emory McTyre, Pierre Triozzi

Sci Rep· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries.
Claire M Lanier, Ryan Hughes, Tamjeed Ahmed, Michael LeCompte, Adrianna H Masters, Pierre Triozzi

Neurooncol Pract· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.
Narges K Tafreshi, Christopher J Tichacek, Darpan N Pandya, Michael L Doligalski, Mikalai M Budzevich, Pierre L Triozzi

J Nucl Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes.
Nikunj B Bhatt, Darpan N Pandya, William A Dezarn, Frank C Marini, Dawen Zhao, Pierre L Triozzi

Methods Mol Biol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.
Marcelo Bonomi, Tamjeed Ahmed, Safoa Addo, Mitra Kooshki, Dario Palmieri, Pierre L Triozzi

Oncol Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy.
Shailaja Raj, Lance D Miller, Pierre L Triozzi

Sarcoma· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Alexandra Thomas, Eric D Routh, Ashok Pullikuth, Guangxu Jin, Jing Su, Pierre Triozzi

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma.
Jason Chesney, Sanjay Awasthi, Brendan Curti, Laura Hutchins, Gerald Linette, Pierre Triozzi

Melanoma Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone.
Michael C LeCompte, Emory McTyre, Adrianna Henson, Michael Farris, Catherine Okoukoni, Pierre Triozzi

Cureus· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis